Kidney Cancer Trial, Recruiting NCT02087852 Sponsor: Memorial Sloan Kettering Cancer Center Condition: Kidney Cancer
Back to Kidney Cancer

Kidney Cancer Trial, Recruiting

NCT02087852
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Kidney Cancer Group:

  • People aged 18 or older who speak English and have been diagnosed with kidney cancer, or where kidney cancer is suspected

Family Member Group:

  • People aged 18 or older who speak English and are a blood relative of someone already enrolled in the kidney cancer group — this includes parents, siblings, half-siblings, children, grandparents, aunts, and uncles. Blood relatives do not need to have kidney cancer themselves to be eligible for this group

Control Group:

  • People aged 18 or older who speak English, have no personal history of cancer (except certain common skin cancers), and are not related by blood to anyone else enrolled in the trial

Who may not be able to join:

  • People who, in the opinion of the treating doctor or trial investigator, have a condition that would prevent them from being able to give informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jonathan Jonathan, MD, Memorial Sloan Kettering Cancer Center

Phone: 646-422-4432

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2014
Est. completion
1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

establish a kidney cancer registry

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov